SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-021924
Filing Date
2019-04-29
Accepted
2019-04-29 16:04:03
Documents
4
Period of Report
2019-06-13
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv519714_def14a.htm DEF 14A 324899
2 GRAPHIC tv519714_img01.jpg GRAPHIC 8724
3 GRAPHIC tv519714_img02.jpg GRAPHIC 291291
4 GRAPHIC tv519714_img03.jpg GRAPHIC 151682
  Complete submission text file 0001144204-19-021924.txt   948601
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36598 | Film No.: 19775850
SIC: 2834 Pharmaceutical Preparations